Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers buys rights to potential HIV drug in deal that could be worth up to $286 million
Bristol-Myers buys rights to potential HIV drug in deal that could be worth up to $286 million
Bristol-Myers buys rights to potential HIV drug in deal that could be worth up to $286 million
Submitted by
admin
on December 20, 2010 - 11:51am
Source:
Yahoo/AP
News Tags:
HIV
Bristol-Myers Squibb
Oncolys BioPharma
Headline:
Bristol-Myers buys rights to potential HIV drug in deal that could be worth up to $286 million
Do Not Allow Advertisers to Use My Personal information
